Methyl 5-bromo-1-methyl-1H-benzo[d][1,2,3]triazole-7-carboxylate, 97%, 500mg

1-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-1,4-DIAZEPANE, 95%, 1g

2-(4-methoxyphenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine, 95.0%, 2g

(3-phenylpropyl)(propyl)amine, 95.0%, 1g

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylic acid, 95.0%, 25g

Methyl 2-(2-formylphenyl)acetate, 90.0%, 100mg

[1-[(3,5-Dimethyl-1H-pyrrol-2-yl)(3,5-dimethyl-2H-pyrrol-2-ylidene)methyl]-4-iodobenzene](difluoroborane)>98.0%(HPLC)200mg

4,6-Dibromo-3-hydroxypicolinonitrile, 98%, 5g

3-Methyl-2-nitrobenzyl bromide, 10g

tert-butyl methyl ether, min. 99.5%, for synthesis, 2.5 l, glass packaging

2,4-Dichlorobenzotrichloride>99.0%(GC)25g

1-(Pyridin-4-ylmethyl)-1H-pyrazol-4-amine, 95.0%, 250mg

3-(piperidin-3-yl)benzoic acid hydrochloride, 95.0%, 100mg